Perigon Wealth Management »

4d Molecular Therapeutics In shares owned by Perigon Wealth Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Perigon Wealth Management from 13F filings

Historical chart of Perigon Wealth Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Perigon Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.7M 146k 31.86
2023-12-31 $5.0M 246k 20.26
2023-09-30 $3.1M 246k 12.73
2023-06-30 $4.4M 246k 18.07
2023-03-31 $4.2M 246k 17.19
2022-12-31 $5.5M 246k 22.21
2022-09-30 $2.0M 251k 8.04
2022-06-30 $2.4M 349k 6.98
2022-03-31 $8.4M 558k 15.12
2021-12-31 $17M 767k 21.94
2011-09-30 $2.0M 251k 8.04